I have lamented elsewhere that really really need not just a diagnostic biomarker for ME but also for PEM. Its so easy to get into blurred arguments simply because we do not really understand what ME and PEM are. We do however have a good understanding of aspects of the pathophysiology.
To me the current focus of the debate is more about energy deficit, and how that happens, than PEM. PEM is associated with energy deficit, but you can be a severe patient, not engaging in activity, and be in a very bad way. No PEM required. I have put forward the hypothesis quite a few times now, though slightly differently to here, that very severe patients do not make enough energy via the aerobic system for their body to properly manage the basic housekeeping functions. In theory you could run a metabolic rate test on severe patients and show major deficits without resorting to CPET.
We seem to get PEM when there is a demand on our energy system, and we cannot manage it. The body then goes into alternative pathways. In the test tube this can be shown by a salt stress test on blood cells using the nanoneedle. In CPET its repeat exercise testing, looking particularly at power output on day 2 of the test.
I think this focus on PEM is due to both historical reasons (its what is usually different to other diseases, even MS) and now we have CPET to measure aerobic energy capacity and how it changes after activity. We have the test, we will investigate this angle. Other angles are not investigated I think because we either lack the technology to do it properly, or are not aware of the technology to do it properly.
I think energy deficit is a core principle. PEM and fatigue are most likely both secondary to that. However in a clinical workup a clinician can ask questions related to both PEM and fatigue and get a better sense of what is going on, even before advanced testing.
The second issue seems to be that activity causes a crash in energy availability. This is the opposite of what usually happens with healthy people.
One recent hypothesis about PEM is that its due to ammonia build-up from excessive use of protein for energy in us. This can now be tested for, but so far the Open Medicine group has not done so . . . I think because the pandemic has stuffed up the testing schedule. Similarly they designed a nanoneedle that can test 100 samples instead of one at the same time, but its delayed because the pandemic has caused issues with manufacturing the device.
I probably have more to say but I need to shut down my computer, lightning is raining down outside.
To me the current focus of the debate is more about energy deficit, and how that happens, than PEM. PEM is associated with energy deficit, but you can be a severe patient, not engaging in activity, and be in a very bad way. No PEM required. I have put forward the hypothesis quite a few times now, though slightly differently to here, that very severe patients do not make enough energy via the aerobic system for their body to properly manage the basic housekeeping functions. In theory you could run a metabolic rate test on severe patients and show major deficits without resorting to CPET.
We seem to get PEM when there is a demand on our energy system, and we cannot manage it. The body then goes into alternative pathways. In the test tube this can be shown by a salt stress test on blood cells using the nanoneedle. In CPET its repeat exercise testing, looking particularly at power output on day 2 of the test.
I think this focus on PEM is due to both historical reasons (its what is usually different to other diseases, even MS) and now we have CPET to measure aerobic energy capacity and how it changes after activity. We have the test, we will investigate this angle. Other angles are not investigated I think because we either lack the technology to do it properly, or are not aware of the technology to do it properly.
I think energy deficit is a core principle. PEM and fatigue are most likely both secondary to that. However in a clinical workup a clinician can ask questions related to both PEM and fatigue and get a better sense of what is going on, even before advanced testing.
The second issue seems to be that activity causes a crash in energy availability. This is the opposite of what usually happens with healthy people.
One recent hypothesis about PEM is that its due to ammonia build-up from excessive use of protein for energy in us. This can now be tested for, but so far the Open Medicine group has not done so . . . I think because the pandemic has stuffed up the testing schedule. Similarly they designed a nanoneedle that can test 100 samples instead of one at the same time, but its delayed because the pandemic has caused issues with manufacturing the device.
I probably have more to say but I need to shut down my computer, lightning is raining down outside.
Last edited: